Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Open Label, Single Center, Single-Dose, Cross-Over Study to Determine the Absolute Bioavailability and the Nasopharyngeal Absorption of PMI-150 (Intranasal Ketamine) in Healthy Adult Volunteers

To see complete record on, please visit this link

Id: NCT00520169

Organisation Name: Javelin Pharmaceuticals

Overal Status: Completed

Start Date: July 2007

Last Update: January 10, 2008

Lead Sponsor: Javelin Pharmaceuticals

Brief Summary: This is an open label, single-center study to determine the absolute bioavailability and nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.

  • Healthy

Total execution time in seconds: 0.28021001815796